Diego Brancaccio
Renal Unit Simone Martini
Milan
Italy
Name/email consistency: high
- CKD-MBD: an endless story. Brancaccio, D., Cozzolino, M. J. Nephrol. (2011)
- Vitamin D receptor activator selectivity in the treatment of secondary hyperparathyroidism: understanding the differences among therapies. Brancaccio, D., Bommer, J., Coyne, D. Drugs (2007)
- Management of secondary hyperparathyroidism in uremic patients: the role of the new vitamin D analogs. Brancaccio, D., Cozzolino, M., Galassi, A., Chiarelli, G., Butti, A., Bellasi, A., Rocca-Rey, L., Volpi, A., Anelli, A., Zoni, U., Fusaro, M., Brambilla, C., Missaglia, E., Crovetto, C., Russo, M., Longhini, C., Provenzano, R., Incalcaterra, F., Cerasola, G., Li Vecchi, M., Gallieni, M. J. Nephrol. (2007)
- The continuous challenge of cardiovascular and bone and bone disease in uremic patients: clinical consequences of hyperphosphatemia and advanced therapeutic approaches. Brancaccio, D., Zoccali, C. J. Nephrol. (2006)
- The mechanism of calcium deposition in soft tissues. Brancaccio, D., Cozzolino, M. Contrib. Nephrol (2005)
- Matrix GLA protein gene polymorphisms: clinical correlates and cardiovascular mortality in chronic kidney disease patients. Brancaccio, D., Biondi, M.L., Gallieni, M., Turri, O., Galassi, A., Cecchini, F., Russo, D., Andreucci, V., Cozzolino, M. Am. J. Nephrol. (2005)
- Hyperparathyroidism and anemia in uremic subjects: a combined therapeutic approach. Brancaccio, D., Cozzolino, M., Gallieni, M. J. Am. Soc. Nephrol. (2004)
- Severe cortical and trabecular osteopenia in secondary hyperparathyroidism. Brancaccio, D., Di Leo, C., Bestetti, A., Carpani, P., Tagliabue, L., Cozzolino, M., Galassi, A., Luigi Tarolo, G., Gallieni, M. Hemodial. Int (2003)
- Bone disease in uremic patients: advances in PTH suppression. Brancaccio, D., Cozzolino, M., Gorio, A., Di Giulio, A.M., Gallieni, M. J. Nephrol. (2002)